Unit

Laboratory of Therapeutic Proteins and Peptides

Laboratory
Summary

The Laboratory of Therapeutic Protein and Peptides at EPFL focuses on developing new therapeutics based on cyclic peptides. They specialize in in vitro evolution of bicyclic peptides using phage display technology and high-throughput synthesis of macrocycles. The ultimate goal is to address unmet medical needs by developing drugs that can engage with challenging protein targets. Recent publications include the development of small cyclic peptides that are orally bioavailable, high-affinity peptides against calprotectin, and the synthesis of large macrocycle diversities. The lab actively participates in various international conferences and symposiums related to peptide therapeutics and drug discovery.

Official source
About this result
This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.